Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-02-09 @ 9:32 PM
Study NCT ID:
NCT06622005
Status:
RECRUITING
Last Update Posted:
2025-04-16
First Post:
2024-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Roswell Park Cancer Institute
Organization: